STABOLY

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jun 2024 filing date already counts against anyone who files later.

Record

Serial number

98619367

Mark type

Design + words

Filed

26 Jun 2024

Published for opposition

01 Apr 2025

Attorney of record

Tara Reedy Sliva

Goods and services

• Class 001 — Chemicals: Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for scientific and research use in the field of microbiology and molecular biology; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis research purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
• Class 005 — Pharmaceuticals: Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities, for medical treatment purpose and diagnostic use; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties for treating blood disorders, autoimmune diseases, and allergic conditions; Organic chemical preparations and enzymes for medical laboratory diagnostic analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory diagnostic analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); biochemical and organic chemical reagents for clinical diagnostic laboratory use

Owner

• Biosynth AG, Staad, CH
• Biosynth AG, Staad, CH

Prosecution history

• 31 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
• 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 01 Apr 2025 — PUBLISHED FOR OPPOSITION
• 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 06 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 13 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 13 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 13 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 22 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 22 Jan 2025 — NON-FINAL ACTION E-MAILED
• 22 Jan 2025 — NON-FINAL ACTION WRITTEN
• 21 Jan 2025 — ASSIGNED TO EXAMINER
• 19 Jan 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 19 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED